US vice president Joe Biden calls for greater collaboration to cure cancer

7 June 2016

The vice president of the United States Joe Biden has called for greater collaboration across the oncology treatment community in the fight against cancer.

In a rallying cry to more than 35,000 delegates at the American Society of Clinical Oncology (ASCO) annual meeting on Monday, Vice President Biden urged everyone to get behind the White House National Cancer Moonshot Initiative, launched by President Obama earlier this year.

Led by the vice president, the $1bn cancer ‘moonshot’ aims to double the rate of progress towards a cure for cancer by making a decade’s worth of advances in five years.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK